RPG Life Sciences Limited
RPG Life Sciences Limited Fundamental Analysis
RPG Life Sciences Limited (RPGLIFE.NS) shows strong financial fundamentals with a PE ratio of 15.62, profit margin of 30.07%, and ROE of 40.64%. The company generates $6.7B in annual revenue with strong year-over-year growth of 13.15%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 78.2/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze RPGLIFE.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentRPGLIFE.NS demonstrates superior asset utilization.
Valuation Score
ExcellentRPGLIFE.NS trades at attractive valuation levels.
Growth Score
ModerateRPGLIFE.NS shows steady but slowing expansion.
Financial Health Score
ExcellentRPGLIFE.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateRPGLIFE.NS maintains healthy but balanced margins.
Key Financial Metrics
Is RPGLIFE.NS Expensive or Cheap?
P/E Ratio
RPGLIFE.NS trades at 15.62 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, RPGLIFE.NS's PEG of -2.63 indicates potential undervaluation.
Price to Book
The market values RPG Life Sciences Limited at 5.72 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 21.21 times EBITDA. This signals the market has high growth expectations.
How Well Does RPGLIFE.NS Make Money?
Net Profit Margin
For every $100 in sales, RPG Life Sciences Limited keeps $30.07 as profit after all expenses.
Operating Margin
Core operations generate 23.94 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $40.64 in profit for every $100 of shareholder equity.
ROA
RPG Life Sciences Limited generates $28.71 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
RPG Life Sciences Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
RPG Life Sciences Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
RPGLIFE.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
15.62
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-2.63
vs 25 benchmark
P/B Ratio
Price to book value ratio
5.72
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.70
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.40
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.41
vs 25 benchmark
ROA
Return on assets percentage
0.29
vs 25 benchmark
ROCE
Return on capital employed
0.29
vs 25 benchmark
How RPGLIFE.NS Stacks Against Its Sector Peers
| Metric | RPGLIFE.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 15.62 | 29.45 | Better (Cheaper) |
| ROE | 40.64% | 779.00% | Weak |
| Net Margin | 30.07% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 3.40 | 4.65 | Strong Liquidity |
| ROA | 28.71% | -19344.00% (disorted) | Strong |
RPGLIFE.NS outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews RPG Life Sciences Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
77.02%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
531.68%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
55.20%
Industry Style: Defensive, Growth, Innovation
High Growth